Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

Release Jan 10 - Barinthus Bio: In a shift to focus on immunology and inflammation indications, the biotech is halting further development of VTP-300 for chronic hepatitis B viral infection and ...

“If small biotech companies like ours are forced to scale back or shut down, it will not just be a loss for scientific ...

Dr. Singh urged states to establish ‘BioE3 Cells’ in collaboration with the Centre through the Department of Biotechnology ...

By fusing circular dichroism with high-resolution microspectroscopy and microscopic imaging, this cutting-edge technology is ...

AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...